Boxer Capital, LLC’s Apellis Pharmaceuticals Inc Position
Does Boxer Capital, LLC own Apellis Pharmaceuticals Inc (APLSUSD)? Not currently — the last reported position was 1.73M shares worth $50M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.
Position Value
$50M
Q3 2024
Shares
1.73M
% of Portfolio
+2.44%
Quarters Held
13
position exited
Position History APLSUSD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 1.73M | $50M | +2.44% |
| Q2 2024 | 1.73M | $66M | +3.49% |
| Q1 2024 | 1.73M | $101M | +5.01% |
| Q4 2023 | 1.73M | $103M | +5.15% |
| Q3 2023 | 1.73M | $66M | +3.50% |
| Q2 2023 | 1.58M | $143,574 | +6.66% |
| Q1 2023 | 1.58M | $103,953 | +5.11% |
| Q4 2022 | 1.58M | $81M | +4.30% |
| Q3 2022 | 1.30M | $89M | +5.01% |
| Q2 2022 | 1.30M | $59M | +3.73% |
| Q1 2022 | 1.30M | $66M | +3.40% |
| Q4 2019 | 800.0K | $24M | +1.39% |
| Q3 2019 | 700.0K | $17M | +1.22% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of APLSUSD.